NCT03915002View on ClinicalTrials.gov

Integrated Approaches for Identifying Molecular Targets in Liver Disease

CompletedOBSERVATIONAL
Enrollment

155

Participants

Timeline

Start Date

June 13, 2019

Primary Completion Date

April 12, 2023

Study Completion Date

April 12, 2023

Conditions
Alcoholic Liver DiseaseNon-Alcoholic Fatty Liver DiseaseSteatohepatitis, NonalcoholicSteatohepatitis
Trial Locations (1)

15213

University of Pittsburgh Medical center, Pittsburgh

All Listed Sponsors
lead

University of Pittsburgh

OTHER

NCT03915002 - Integrated Approaches for Identifying Molecular Targets in Liver Disease | Biotech Hunter | Biotech Hunter